115 related articles for article (PubMed ID: 38880817)
1. External validation of the modified CTP score based on ammonia to predict survival in patients with cirrhosis after TIPS placement.
Da B; Wu W; Guo W; Xiong K; Chen C; Ke Q; Zhang M; Li T; Xiao J; Wang L; Zhang M; Zhang F; Zhuge Y
Sci Rep; 2024 Jun; 14(1):13886. PubMed ID: 38880817
[TBL] [Abstract][Full Text] [Related]
2. FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.
Yang C; Chen Q; Zhou C; Liu J; Huang S; Wang Y; Wang C; Ju S; Chen Y; Li T; Bai Y; Yao W; Xiong B
AJR Am J Roentgenol; 2022 Aug; 219(2):255-267. PubMed ID: 35138134
[No Abstract] [Full Text] [Related]
3. Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt.
Zhang F; Zhuge Y; Zou X; Zhang M; Peng C; Li Z; Wang T
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):853-60. PubMed ID: 24915489
[TBL] [Abstract][Full Text] [Related]
4. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.
Zhang B; Cai W; Gao F; Lin X; Qian T; Gu K; Song B; Chen T
Med Sci Monit; 2022 Jan; 28():e934057. PubMed ID: 35031594
[TBL] [Abstract][Full Text] [Related]
6. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
Khabbaz RC; Lokken RP; Chen YF; Lipnik AJ; Bui JT; Ray CE; Gaba RC
Cardiovasc Intervent Radiol; 2018 Jul; 41(7):1029-1034. PubMed ID: 29516241
[TBL] [Abstract][Full Text] [Related]
7. MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
Song J; Wang X; Yan Y; Xiang T; Luo X
Dig Dis Sci; 2023 Jul; 68(7):3185-3192. PubMed ID: 36715817
[TBL] [Abstract][Full Text] [Related]
8. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
[TBL] [Abstract][Full Text] [Related]
9. Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.
Song J; Wang X; Yan Y; Xiang T; Luo X
Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1074-1080. PubMed ID: 36062497
[TBL] [Abstract][Full Text] [Related]
10. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.
Salerno F; Merli M; Cazzaniga M; Valeriano V; Rossi P; Lovaria A; Meregaglia D; Nicolini A; Lubatti L; Riggio O
J Hepatol; 2002 Apr; 36(4):494-500. PubMed ID: 11943420
[TBL] [Abstract][Full Text] [Related]
11. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
[TBL] [Abstract][Full Text] [Related]
12. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
Lee DH; Son JH; Kim TW
Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
[TBL] [Abstract][Full Text] [Related]
13. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
Young S; Rostambeigi N; Golzarian J; Lim N
AJR Am J Roentgenol; 2020 Jul; 215(1):215-222. PubMed ID: 32432911
[No Abstract] [Full Text] [Related]
14. Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension.
Chen R; Luo L; Zhang YZ; Liu Z; Liu AL; Zhang YW
World J Gastroenterol; 2024 Apr; 30(13):1859-1870. PubMed ID: 38659484
[TBL] [Abstract][Full Text] [Related]
15. Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.
Hu XG; Yang XX; Lu J; Li G; Dai JJ; Wang JM; Deng Y; Feng R
World J Gastrointest Surg; 2024 Feb; 16(2):481-490. PubMed ID: 38463353
[TBL] [Abstract][Full Text] [Related]
16. [Comparison study of five scoring systems for evaluating prognosis of patients undergoing transjugular intrahepatic portosystemic shunt procedures].
Wen L; He S; Zhang H; Luo X
Zhonghua Gan Zang Bing Za Zhi; 2014 Jul; 22(7):514-8. PubMed ID: 25203803
[TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
18. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage.
Tzeng WS; Wu RH; Lin CY; Chen JJ; Sheu MJ; Koay LB; Lee C
Korean J Radiol; 2009; 10(5):481-9. PubMed ID: 19721833
[TBL] [Abstract][Full Text] [Related]
19. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
[TBL] [Abstract][Full Text] [Related]
20. Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt.
Ballester MP; Lluch P; Tosca J; Capilla M; Gómez C; Moreno O; Jordán-Iborra C; Sunsundegui P; Argemi J; Guijarro J; Mínguez M
Dig Liver Dis; 2021 Dec; 53(12):1596-1602. PubMed ID: 34052179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
